Skip to main content

Table 1 Dosimetry data among patients treated with 3DCRT and DIBH

From: Deep-inspirational breath-hold (DIBH) technique in left-sided breast cancer: various aspects of clinical utility

n = 88

WBI (n = 54)

WBI + nodal/PM RT (n = 34)

FB (1)

DIBH (2)

Prone (3)

p

p (post hoc tests)

FB

DIBH

p

1 vs 2

1 vs 3

2 vs 3

PTV HI

0.102 ± 0.017

0.101 ± 0.012

0.105 ± 0.012

0.214

0.362

0.381

0.067

0.122 ± 0.011

0.129 ± 0.013

0.215

Heart mean dose (Gy)

3.16 ± 1.58

1.38 ± 0.37

2.02 ± 1.15

 < 0.001

 < 0.001

 < 0.001

 < 0.001

4.87 ± 1.21

2.13 ± 0.57

 < 0.001

Heart V25 Gy (%)

4.13 ± 3.13

0.46 ± 0.51

1.44 ± 2.21

 < 0.001

 < 0.001

 < 0.001

0.009

6.42 ± 2.43

1.23 ± 0.91

 < 0.001

LAD mean dose (Gy)

13.05 ± 8.30

4.55 ± 1.95

9.98 ± 7.16

 < 0.001

 < 0.001

0.098

 < 0.001

18.95 ± 7.03

7.47 ± 4.39

 < 0.001

LAD max dose (Gy)

39.81 ± 14.52

18.92 ± 12.86

31.99 ± 14.15

 < 0.001

 < 0.001

0.021

 < 0.001

47.03 ± 7.56

31.86 ± 10.83

 < 0.001

Ipsilateral lung mean dose (Gy)

7.01 ± 1.97

6.37 ± 1.44

0.90 ± 0.63

 < 0.001

 < 0.001

 < 0.001

 < 0.001

14.29 ± 2.32

11.29 ± 1.91

 < 0.001

Ipsilateral lung V20Gy (%)

12.11 ± 4.31

10.65 ± 3.17

0.65 ± 1.14

 < 0.001

 < 0.001

 < 0.001

 < 0.001

28.66 ± 5.36

21.64 ± 4.64

 < 0.001

Contralateral breast mean dose (Gy)

0.36 ± 0.34

0.46 ± 0.50

0.59 ± 0.54

0.084

0.098

0.033

0.261

1.45 ± 1.31

1.4 ± 1.07

0.755

Contralateral breast V10 Gy (%)

0.46 ± 0.99

0.82 ± 1.59

0.76 ± 1.31

0.435

0.172

0.287

0.873

2.89 ± 3.32

3.07 ± 3.38

0.685